Simultaneous Carotid Artery Stenting and Coronary Artery Bypass Grafting in Urgent Patients: A Single Center

Mariafrancesca Fiorentino1, Elisa Mikus1, Roberto Nerla1

  • 1Cardiovascular Department, Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.

PubMed

Insights

Simultaneous carotid artery stenting (CAS) and coronary artery bypass grafting (CABG) is safe and effective. This combined procedure shows low mortality, stroke risk, and bleeding complications, with good long-term survival.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coexisting coronary artery disease and critical carotid stenosis pose significant revascularization challenges, especially in urgent surgical scenarios.
  • Combined carotid artery stenting (CAS) and coronary artery bypass grafting (CABG) is an increasingly adopted strategy for managing these complex cases.

Purpose of the Study:

  • To evaluate the safety and efficacy of a simultaneous CAS and CABG procedure.
  • To assess perioperative outcomes, including mortality, stroke, bleeding, and long-term survival.

Main Methods:

  • Analysis of 36 patients undergoing simultaneous CAS and CABG between 2014 and 2024.
  • CAS performed first with awake patient for neurocognitive monitoring; clopidogrel loading dose 3 hours post-op.
  • Dual antiplatelet therapy initiated on postoperative day 1.

Main Results:

  • No in-hospital mortality or postoperative stroke observed in 36 patients.
  • Low median postoperative bleeding (500 mL) with one patient requiring resternotomy.
  • Excellent survival rates: 93.7% at 1 year, 81.5% at 5 years, 60.2% at 10 years.
  • High freedom from percutaneous transluminal coronary angioplasty/percutaneous coronary intervention (PTCA/PCI): 100% at 1 year, 96.7% at 5 years, 87.5% at 10 years.

Conclusions:

  • Simultaneous CAS and CABG is a safe and effective revascularization strategy.
  • The employed protocol demonstrates low perioperative stroke and bleeding risks.
  • Early antiplatelet therapy does not elevate postoperative bleeding complications.